| Jagsonpal Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 507789 |
NSE Symbol : JAGSNPHARM |
P/E(TTM) : 31.50 |
|
ISIN Demat : INE048B01035 |
Div & Yield% : 1.90 |
EPS(TTM) : 6.65 |
|
Book Value(₹) : 41.14 |
Market Cap(₹Cr) : 1,406.57 |
Face Value(₹) : 2.00 |
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 64.20 | 72.95 | 74.47 | 75.61 | 58.56 | 74.03 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 64.20 | 72.95 | 74.47 | 75.61 | 58.56 | 74.03 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 3.17 | 2.98 | 3.03 | 2.83 | 2.77 | 25.51 |
| Total Income | 67.37 | 75.92 | 77.49 | 78.44 | 61.33 | 99.53 |
| Total Expenditure | 53.04 | 58.76 | 58.03 | 61.40 | 50.06 | 58.19 |
| PBIDT | 14.33 | 17.16 | 19.46 | 17.04 | 11.27 | 41.34 |
| Interest | 0.25 | 0.26 | 0.27 | 0.25 | 0.26 | 0.26 |
| PBDT | 14.08 | 16.91 | 19.20 | 16.78 | 11.01 | 41.09 |
| Depreciation | 2.32 | 2.39 | 2.39 | 2.35 | 2.31 | 2.41 |
| Tax | 2.46 | 3.75 | 3.81 | 3.17 | 1.24 | 8.06 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.53 | -0.18 | 0.43 | 0.47 | 0.89 | -1.38 |
| Reported Profit After Tax | 8.76 | 10.95 | 12.57 | 10.80 | 6.58 | 31.99 |
| Extra-ordinary Items | 0.00 | -1.54 | 0.00 | 0.00 | -0.16 | 18.35 |
| Adjusted Profit After Extra-ordinary item | 8.76 | 12.49 | 12.57 | 10.80 | 6.74 | 13.64 |
| EPS (Unit Curr.) | 1.25 | 1.67 | 1.88 | 1.60 | 0.98 | 4.74 |
| EPS (Adj) (Unit Curr.) | 1.25 | 1.67 | 1.88 | 1.60 | 0.98 | 1.90 |
| Calculated EPS (Unit Curr.) | 1.31 | 1.64 | 1.89 | 1.62 | 0.99 | 4.84 |
| Calculated EPS (Adj) (Unit Curr.) | 1.31 | 1.64 | 1.89 | 1.62 | 0.99 | 1.94 |
| Calculated EPS (Ann.) (Unit Curr.) | 5.23 | 6.56 | 7.55 | 6.49 | 3.97 | 19.35 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 5.23 | 6.56 | 7.55 | 6.49 | 3.97 | 7.74 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 13.39 | 13.36 | 13.33 | 13.31 | 13.28 | 13.23 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 22.32 | 23.52 | 26.13 | 22.54 | 19.25 | 55.84 |
| PBDTM(%) | 21.93 | 23.18 | 25.78 | 22.19 | 18.80 | 55.50 |
| PATM(%) | 13.64 | 15.01 | 16.88 | 14.28 | 11.24 | 43.21 |
